Best peptides for sleep.

A category with real search demand, a memorable name at the centre of it, and a trial record that almost nobody quotes.

Ranked by published evidence · reviewed June 1, 2026

Delta sleep-inducing peptide is the compound most people mean when they ask about peptides for sleep, and its name is doing an enormous amount of work. It was identified in the 1970s in rabbits, named for an association with delta-wave sleep, and that name has carried its reputation ever since.

The human record is thinner than the name suggests. Where the compound has been studied in people, the results have not established a reliable sleep benefit, and the literature is old, small, and not followed up in the way a promising sleep agent would be. The gap between the strength of the name and the strength of the data is the central fact about this compound.

The remaining compounds in the category are adjacent rather than direct. Some are pineal-associated peptides whose sleep connection runs through melatonin regulation as a mechanism rather than through sleep outcomes measured in trials. Others are anxiolytic compounds where improved sleep would be a downstream consequence of reduced anxiety rather than a direct effect, and where the anxiolytic evidence itself is largely single-region.

Sleep is also a domain where subjective report and objective measurement diverge sharply, and where expectation effects are large. Sleep quality is one of the most placebo-responsive outcomes in medicine, which makes uncontrolled personal experience an especially weak guide here.

The honest verdict

Small category, old and unimpressive human data, and a compound whose reputation rests substantially on its name. There is no peptide with established sleep efficacy.

Ranked by evidence.

Ordered by PepCue's evidence tier, not by claimed effect size. A compound with a larger reported result but less human data ranks below one that has actually been tested.

FAQ.

Does DSIP improve sleep?

Its name reflects an association observed in early animal work, not a demonstrated clinical effect. The human studies that exist are old and small and have not established a reliable benefit.

Why is this category so small?

Because sleep is well served by drugs that have actually been through trials, so there has been limited pharmaceutical incentive to develop peptide alternatives, and the peptides that were investigated did not produce compelling results.